Lv51
1130 积分 2023-11-24 加入
Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression
2小时前
待确认
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery
1个月前
已完结
Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer
1个月前
已完结
Engineering immune-evasive allogeneic cellular immunotherapies
1个月前
已完结
γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors
2个月前
已完结
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
2个月前
已完结
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
3个月前
已完结
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
3个月前
已完结
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
4个月前
已完结
A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
4个月前
已完结
皖公网安备34019202002308
